Doenças associadas ao HPV: rastreamento, vacinas profiláticas e terapêuticas

• Processo: 24/19386-0
• Modalidade de apoio: Auxílio Organização - Reunião Científica
• Data de Início da vigência: 11 de setembro de 2025
• Data de Término da vigência: 13 de setembro de 2025
• Área do conhecimento: Ciências da Saúde - Saúde Coletiva - Epidemiologia
• Pesquisador responsável: Laura Cristina Sichero Vettorazzo
• Beneficiário: Laura Cristina Sichero Vettorazzo
• Instituição Sede: Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira (ICESP). São Paulo , SP, Brasil
• Município da Instituição Sede: São Paulo
• Assunto(s): Neoplasias do colo uterino Infecções por Papillomavirus Rastreamento Vacinas Epidemiologia molecular
• Palavra(s)-Chave do Pesquisador: Câncer de colo de útero | papilomavírus humano | Rastreamento | vacina profilática | vacina terapêutica | Epidemiologia Molecular

Resumo

The event will benefit basic and clinical researchers. No parallel sessions are planned. The event starts with an educational session, where HPV structure, taxonomy, life cycle, carcinogenesis and immune responses are presented. This educational session expects to bring current information on the topics so that even non-specialists are updated. The event will consist of 9 sessions of 40 min lectures by international/national experts, followed by 15 min oral presentations within the topic. These include HPV associated diseases, cervical cancer screening and prophylactic and therapeutic vaccines. Lectures will be conducted by experts who have ongoing collaborations or are planning joint projects or whose expertise benefit researchers and clinicians in these areas. Oral presentations will be selected from abstracts. At the end of each day, a 30-mi seminar on topics relevant are programmed. Poster sections will occur in two days, and posters will be evaluated by invited speakers and the scientific committee, and best posters in distinct categories will be awarded. Our main goal is to promote interaction between regional and international leaders in epidemiology, screening and treatment of cervical and other HPV malignancies, offering unique opportunities for networking. We aim to strengthen on-going collaborations and promote new ones with both international and national leaders. Early career participants will benefit from a better understanding of topics discussed and may be better able to navigate the details of building a career and research program involving topic discussed. Invited speakers will be available to discuss during poster sessions and coffee breaks, and the 90-minute meet the expert's period. Thus, there will be ample opportunities to interact during talks, poster presentations and social activities. In fact, onsite participation offers increased contact between speakers and participants. The auditorium at ICESP has a capacity for 180 people. (AU)